Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote CHF

CPH Group AG (0QNZ.L)

Compare
60.80
-3.00
(-4.70%)
As of April 9 at 11:47:36 AM GMT+1. Market Open.
Loading Chart for 0QNZ.L
  • Previous Close 63.80
  • Open 60.80
  • Bid --
  • Ask --
  • Day's Range 60.80 - 60.80
  • 52 Week Range 60.80 - 92.60
  • Volume 29
  • Avg. Volume 67
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) --
  • EPS (TTM) -25.26
  • Earnings Date Feb 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. The Chemistry division develops, manufactures, and distributes a range of molecular sieves, special zeolites, chromatography gels, and deuterated solvents under the Zeochem brand name. The Packaging division provides a range of PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry under the Perlen Packaging brand name. The company also manufactures newsprint and magazine paper products. CPH Group AG was founded in 1818 and is based in Root, Switzerland.

cph.ch

959

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0QNZ.L

View More

Performance Overview: 0QNZ.L

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0QNZ.L
18.28%
MSCI WORLD (^990100-USD-STRD)
5.18%

1-Year Return

0QNZ.L
0.00%
MSCI WORLD (^990100-USD-STRD)
4.02%

3-Year Return

0QNZ.L
0.00%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

0QNZ.L
0.00%
MSCI WORLD (^990100-USD-STRD)
78.40%

Compare To: 0QNZ.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0QNZ.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.04%

  • Return on Assets (ttm)

    4.03%

  • Return on Equity (ttm)

    1.44%

  • Revenue (ttm)

    447.86M

  • Net Income Avi to Common (ttm)

    4.65M

  • Diluted EPS (ttm)

    -25.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    31.6M

  • Total Debt/Equity (mrq)

    9.04%

  • Levered Free Cash Flow (ttm)

    31.38M

Research Analysis: 0QNZ.L

View More

Company Insights: 0QNZ.L

Research Reports: 0QNZ.L

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.